Today, World Alzheimer's Day, we join the community to raise awareness of the need for better care, support, and research to improve the lives of those affected by Alzheimer's and other forms of dementia.
A major research effort is the European Platform for Neurodegenerative Diseases (EPND), a public-private partnership funded by the Innovative Medicines Initiative (IMI), a joint undertaking between the EU and European pharmaceutical industries supporting projects at the health research vanguard.
Svar is proud to be part of this collective effort to accelerate the understanding and management of neurodegenerative diseases. By combining our expertise with that of other partners in EPND, we hope to make significant strides towards improving the lives of patients and their families affected by debilitating conditions like Alzheimer's